Screener / SEC EDGAR /CIK 0000790526 /10-K filed Mar 2, 2026, compared with Mar 3, 2025 /Numbers from the XBRL of the 10-Ks
Nasdaq Health care · Medical Labs

RadNet, Inc. RDNT

Compare with peers Embed
Earnings releases

Latest results release: Nov 9, 2026

8-K item 2.02, exhibit 99

What RDNT's management wrote with each quarter's results: the press release and, when the company files them, its prepared remarks or the call transcript. The call itself is not filed with SEC, so most quarters have the release only.

Adjusted vs GAAP earnings per share

In the company's own words · read from each release, never computed

What the company says its adjusted numbers leave out:

Adjusted EBITDA should not be considered a measure of financial performance under GAAP, and the items excluded from Adjusted EBITDA should not be considered in isolation or as alternatives to net income, cash flows generated by operating, investing or financing activities or other financial statement data presented in the consolidated financial statements as an indicator of financial performance or liquidity. release Nov 9, 2026

Both numbers are read from the words of each release (usually the highlights), never computed by us; hover a number for its sentence. Quarters where the release gives them only in a table are not shown. The company decides what "adjusted" leaves out; the full reconciliation is in the release.

Read and search

Every release, in full · linked to sec.gov

Press release Nov 9, 2026 · EX-99.1

RadNet Reports Third Quarter Financial Results with Record Quarterly Revenue and

Open on SEC

Exhibit 99.1 FOR IMMEDIATE RELEASE RadNet Reports Third Quarter Financial Results with Record Quarterly Revenue and Adjusted EBITDA (1)and Revises Upwards 2026 Financial Guidance Ranges

Total Company Revenue increased 22.1% to $638.3 million in the third quarter · of 2026 from $522.9 million in the third quarter of 2025; Revenue from the Digital Health reportable segment (inclusive of intersegment revenue) increased 32.6% to $32.9 million in the third quarter of 2026 from $24.8 million in the third quarter of 2025 Total Company Adjusted EBITDA(1) was $105.0 million in the third quarter of 2026 as compared with $84.9 million in the third quarter · of 2025, an increase of 23.8%; Digital Health reportable segment Adjusted EBITDA(1) decreased 11.8% to $3.0 million in the third quarter of 2026 from $3.5 million in the third quarter of 2025 Total Company Adjusted EBITDA(1) margin increased to 16.5% · in the third quarter of 2026 as compared with 16.2% in the third quarter of 2025 Adjusting for unusual or one-time items in the quarter, Adjusted Diluted · Earnings Per Share(3) was $0.30 for the third quarter of 2026; This compares with Adjusted Diluted Earnings Per Share(3) of $0.24 for the third quarter of 2025 In the third quarter of 2026, aggregate advanced imaging (MRI, CT and · PET/CT) procedural volumes increased 19.9% and same-center advanced imaging procedural volumes increased 8.9% as compared with the third quarter of 2025 · As of September 30, 2026, we had a cash balance of $750.6 million and Net Debt to Adjusted EBITDA(1) ratio of 1.66x · RadNet revises full-year 2026 guidance levels to increase Imaging Center Revenue, Adjusted EBITDA(1)and Free Cash Flow(2) ranges

LOS ANGELES, California, November 8, 2026 – RadNet, Inc. (NASDAQ: RDNT), a national leader in providing high-quality, cost-effective outpatient diagnostic imaging services and a premier global developer of digital health solutions, today reported financial results for its third quarter of 2026.

Dr. Howard Berger, President and Chief Executive Officer of RadNet, commented, “We delivered record quarterly Revenue and Adjusted EBITDA in the third quarter. Total Company Revenue grew 22.1% and Adjusted EBITDA grew 23.8% compared with last year’s third quarter, and Adjusted EBITDA margin expanded 23 basis points. These results were driven by continued initiatives to create and fill capacity at existing imaging centers, new center openings, the continued shift in the business mix towards advanced imaging, tuck-in acquisitions, improved reimbursement from commercial payors, the expansion of our health system joint ventures and 32.6% Revenue growth in the Digital Health segment.”

Dr. Berger continued, “Advanced imaging growth continues to be strong, both in aggregate and on a same-center basis. Compared with last year’s third quarter, aggregate advanced imaging procedural volumes increased 19.9% and same-center advanced imaging procedural volumes increased 8.9%. As a result, RadNet’s advanced imaging business mix increased 232 basis points, from 28.2% of all procedures in the third quarter of 2025 to 30.6% in the third quarter of 2026.”

“With strong performance across nearly every part of the core imaging center business, we are again raising certain guidance ranges in anticipation that full-year results will exceed both our original expectations and the revised ranges issued in conjunction with first and second quarter 2026 results. We are raising 2026 Imaging Center guidance ranges for Revenue, Adjusted EBITDA and Free Cash Flow,” added Dr. Berger.

Dr. Berger continued, “We are particularly excited about the opportunities for growth and expansion that will be made possible as a result of the recently announced pending acquisition of ONRAD. The inbound interest from current joint venture partners and potential new partners and customers has exceeded our expectations. The strategic fit that ONRAD’s capabilities have with both RadNet’s core imaging center business and Digital Health solutions is already being recognized in the imaging marketplace, and we look forward to the opportunities that could result once the acquisition is closed.”

“RadNet’s balance sheet remains healthy and continues to provide the operating flexibility necessary to achieve further growth. We ended the third quarter with $750.6 million in cash and a Net Debt to Adjusted EBITDA leverage ratio of 1.66x. This liquidity enables us to keep investing in organic growth and to pursue attractive strategic acquisitions in the coming quarters,” concluded Dr. Berger.

For the third quarter of 2026, RadNet reported Total Company Revenue of $638.3 million and Adjusted EBITDA of $105.0 million. Revenue increased $115.4 million (or 22.1%) and Adjusted EBITDA increased $20.2 million (or 23.8%) as compared with the third quarter of 2025.

For the third quarter of 2026, RadNet reported Digital Health Revenue (inclusive of intersegment revenue) of $32.9 million and Adjusted EBITDA of $3.0 million. Revenue increased $8.1 million (or 32.6%) and Adjusted EBITDA decreased $0.4 million (or -11.8%) as compared with the third quarter of 2025.

Unadjusted for unusual or one-time items impacting the third quarter, Total Company Net Income for the third quarter of 2026 was $4.2 million as compared with a Total Company Net Income of $5.4 million for the third quarter of 2025. Fully diluted Net Income Per Share for the third quarter of 2026 was $0.05, compared with a fully diluted Net Income Per Share of $0.07 in the third quarter of 2025, based upon a weighted average number of diluted shares outstanding of 79.2 million shares in the third quarter of 2026 and 77.4 million shares in the third quarter of 2025.

There were a number of unusual, one-time and noteworthy items impacting the third quarter including: $1.2 million in severance expense related to cost-savings initiatives; $7.5 million gain on the contribution of imaging centers into joint ventures; $0.6 million expense related to leases for de novo facilities under construction that have yet to open their operations; $5.4 million loss on the disposal of equipment; $7.3 million intangibles amortization expense related to the Digital Health operating segment; $5.6 million of non-capitalized research and development expenses related to the DeepHealth Cloud OS and AI solutions; $2.8 million in legal settlements; $2.7 million of acquisition transaction costs; $8.3 million in non-cash change in contingent consideration; and $2.1 million of lease abandonment charges. Adjusting for the above items, Total Company Adjusted Earnings was $23.8 million and diluted Adjusted Earnings Per Share was $0.30 during the third quarter of 2026. This compares with Total Company Adjusted Earnings of $18.8 million and diluted Adjusted Earnings Per Share of $0.24 during the third quarter of 2025.

For the third quarter of 2026, as compared with the prior year’s third quarter, MRI volume increased 18.3%, CT volume increased 22.0% and PET/CT volume increased 30.4%. Overall volume, taking into account routine imaging exams, inclusive of x-ray, ultrasound, mammography and other exams, increased 10.8% over the prior year’s third quarter. On a same-center basis, including only those centers which were part of RadNet for both the third quarters of 2026 and 2025, MRI volume increased 8.2%, CT volume increased 10.2% and PET/CT volume increased 8.2%. Overall same-center volume, taking into account routine imaging exams, inclusive of x-ray, ultrasound, mammography and other exams, increased 3.2% over the prior year’s same quarter

For the first nine months of 2026, RadNet reported Total Company Revenue of $1,836.6 million and Adjusted EBITDA of $268.0 million. Revenue increased $344.1 million (or 23.1%) and Adjusted EBITDA increased $55.4 million (or 26.1%) as compared with the first nine months of 2025.

For the first nine months of 2026, RadNet reported Digital Health Revenue (inclusive of intersegment revenue) of $94.5 million and Adjusted EBITDA of $6.8 million. Revenue increased $29.7 million (or 45.8%) and Adjusted EBITDA decreased $3.7 million (or -35.4%) as compared with the first nine months of 2025.

Unadjusted for one-time or unusual items, Total Company Net Loss for the first nine months of 2026 was $21.8 million as compared with a Total Company Net Loss of $18.1 million for the first nine months of 2025. Fully diluted Net Loss Per Share for the nine month period of 2026 was $(0.28), compared with a fully diluted Net Loss Per Share of $(0.24) in the nine month period of 2025, based upon a weighted average number of diluted shares outstanding of 77.6 million shares for the nine month period in 2026 and 74.7 million shares for the nine month period in 2025.

Revised Revised Revised Original Guidance Guidance Guidance Guidance Range Range After Range After Range After Q1 Q2 Results Q3 Results Results Total Net $2,325 - $2,355 - $2,370 - $2,385 - Revenue $2,375 $2,405 $2,420 $2,435 million million million million Adjusted $335 - $348 $340 - $353 $345 - $358 $350 - $363 EBITDA(1) million million million million Capital $165 - $175 $165 - $175 $165 - $175 $170 - $180 Expenditur… million million million million Cash $45 - $50 $45 - $50 $48 - $53 $48 - $53 Interest million million million million Expense(b) Free Cash $105 - $115 $112 - $122 $115 - $125 $120 - $130 Flow (2) million million million million

Net of proceeds from the sale of equipment and the New Jersey Imaging (a) Network L.L.C. joint venture capital expenditures.

Net of payments received from counterparties on interest rate swaps and (b) interest income from our cash balance recorded in Other Income.

Revised Revised Revised Original Guidance Guidance Guidance Guidance Range After Range After Range After Range Q1 Q2 Q3 Results Results Results Total Net Revenue $135 (inclusive - $145 $135 - $145 $135 - $145 $135 - $145 of million million million million intersegme… revenue) Adjusted EBITDA(1) Before Non-Capita… $10 - $12 $10 - $12 $10 - $12 $11 - $13 R&D - million million million million DeepHealth Cloud OS & Generative AI Non-Capita… R&D - DeepHealth $17 - $19 $17 - $19 $17 - $19 $17 - $19 Cloud million million million million OS & Generative AI Capital $9 - $12 $9 - $12 $9 - $12 $10 - $13 Expenditur… million million million million Free Cash Flow(2) Before Non-Capita… $(1) - $3 $(1) - $3 $(1) - $3 $(1) - $3 R&D - million million million million DeepHealth Cloud OS & Generative AI Free Cash Flow(2) After Non-Capita… $(17) - $(17) - $(17) - $(19) $(17) - R&D - $(19) $(19) million $(19) DeepHealth million million million Cloud OS & Generative AI

Dr. Berger explained, “The Imaging Center segment has outperformed projections in each of the first three quarters of this year. As a result, we are raising its guidance ranges for Revenue, Adjusted EBITDA and Free Cash Flow. In the Digital Health segment, we are raising the Adjusted EBITDA guidance range as a result of effective expense management and faster- than-projected integration of acquired operations.”

Dr. Howard Berger, President and Chief Executive Officer, and Mark Stolper, Executive Vice President and Chief Financial Officer, will host a conference call to discuss its third quarter 2026 results on Monday, November 9th, 2026 at 7:30 a.m. Pacific Time (10:30 a.m. Eastern Time).

It is recommended that participants dial in approximately 5 minutes prior to the start of the 10:30 a.m. call. There will also be simultaneous and archived webcasts available athttps://viavid.webcasts.com/starthere.jsp?ei=1780998&tp_key=f33fc0e8e8 or http://www.radnet.com under the “Investors” menu section and “News Releases” sub-menu of the website. An archived replay of the call will also be available and can be accessed by dialing 844-512-2921 from the U.S., or 412-317-6671 for international callers, and using the passcode 10213035.

RadNet, Inc. is a leading national provider of freestanding, fixed-site diagnostic imaging services in the United States based on the number of locations and annual imaging revenue. RadNet has a network of owned and/or operated outpatient imaging centers. RadNet’s imaging center markets include Arizona, California, Delaware, Florida, Idaho, Indiana, Maryland, New Jersey, New York, Texas and Virginia. In addition, RadNet provides radiology information technology and artificial intelligence solutions marketed under the DeepHealth brand, teleradiology professional services and other related products and services to customers in the diagnostic imaging industry globally. Together with contracted radiologists, and inclusive of full-time and per diem employees and technologists, RadNet has over 12,000 team members. Learn more at www.radnet.com.

This press release contains “forward-looking statements” within the meaning of the safe harbor provisions of the U.S. Private Securities Litigation Reform Act of 1995. Forward-looking statements are expressions of our current beliefs, expectations and assumptions regarding the future of our business, future plans and strategies, projections, and anticipated future conditions, events and trends. Forward-looking statements can generally be identified by words such as: “anticipate,” “intend,” “plan,” “goal,” “seek,” “believe,” “project,” “estimate,” “expect,” “strategy,” “future,” “likely,” “may,” “should,” “will” and similar references to future periods. Forward- looking statements in this press release include, among others, statements about our anticipated business results, balance sheet and liquidity and our future liquidity, burn rate and our continuing ability to service or refinance our current indebtedness.

Forward-looking statements are neither historical facts nor assurances of future performance. Because forward-looking statements relate to the future, they are inherently subject to uncertainties, risks and changes in circumstances that are difficult to predict and many of which are outside of our control. Our actual results and financial condition may differ materially from those indicated in the forward- looking statements. Therefore, you should not place undue reliance on any of these forward-looking statements. Important factors that could cause our actual results and financial condition to differ materially from those indicated in the forward-looking statements include, among others, the following:

· the availability and terms of capital to fund our business; our ability to service our indebtedness, make · principal and interest payments as those payments become due and remain in compliance with applicable debt covenants, in addition to our ability to refinance such indebtedness on acceptable terms; · changes in general economic conditions nationally and regionally in the markets in which we operate; the availability and terms of capital to fund · the expansion of our business and improvements to our existing facilities; our ability to maintain our current credit rating · and the impact on our funding costs and competitive position if we do not do so; our ability to acquire, develop, implement and monetize technology, · digital health initiatives, artificial intelligence algorithms and applications; · volatility in interest and exchange rates, or credit markets; · the adequacy of our cash flow and earnings to fund our current and future operations; · changes in service mix, revenue mix and procedure volumes; · delays in receiving payments for services provided; · increased bankruptcies among our partner physicians or joint venture partners; the impact of the political environment and related · developments on the current healthcare marketplace and on our business, including with respect to the future of the Affordable Care Act; the extent to which the ongoing implementation of healthcare reform, or changes in or new legislation, regulations or · guidance, enforcement thereof by federal and state regulators or related litigation result in a reduction in coverage or reimbursement rates for our services, or other material impacts to our business; closures or slowdowns and changes in labor costs · and labor difficulties, including stoppages affecting either our operations or our suppliers' abilities to deliver supplies needed in our facilities; · the occurrence of hostilities, political instability or catastrophic events; · the emergence or reemergence of and effects related to future pandemics, epidemics and infectious diseases; and noncompliance by us with any privacy or security · laws or any cybersecurity incident or other security breach by us or a third party involving the misappropriation, loss or other unauthorized use or disclosure of confidential information.

Any forward-looking statement contained in this current report is based on information currently available to us and speaks only as of the date on which it is made. We undertake no obligation to publicly update any forward-looking statement, whether written or oral, that we may make from time to time, whether as a result of changed circumstances, new information, future developments or otherwise, except as required by applicable law.

This release contains certain financial information not reported in accordance with GAAP. The Company uses both GAAP and non-GAAP metrics to measure its financial results. The Company believes that, in addition to GAAP metrics, these non-GAAP metrics assist the Company in measuring its cash-based performance. The Company believes this information is useful to investors and other interested parties because it removes unusual and nonrecurring charges that occur in the affected period and provides a basis for measuring the Company's financial condition against other quarters. Such information should not be considered as a substitute for any measures calculated in accordance with GAAP, and may not be comparable to other similarly titled measures of other companies. Non-GAAP financial measures should not be considered in isolation from, or as a substitute for, financial information prepared in accordance with GAAP. Reconciliation of this information to the most comparable GAAP measures is included in this release in the tables which follow.

September 30, December 31, 2026 2025 ────────────────────────────────────────────────────────────────────────────── -unaudited ASSETS CURRENT ASSETS Cash and Cash $ 750,607 $ 767,215 equivalents Accounts 248,893 200,317 receivable Due from 5,600 12,592 affiliates Prepaid expenses and other 63,341 52,003 current assets Total current 1,068,441 1,032,127 assets PROPERTY, EQUIPMENT AND RIGHT-OF-USE ASSETS Property and equipment, 904,274 807,702 net Operating lease 755,606 690,250 right-of-use assets Total property, equipment 1,659,880 1,497,952 and right-of-use assets OTHER ASSETS Goodwill 1,136,986 907,663 Other intangible 235,063 148,508 assets Deferred financing 1,248 1,684 costs Investment in joint 131,507 130,340 ventures Deposits and 47,273 40,289 other Total Assets $ 4,280,398 $ 3,758,563 LIABILITIES AND EQUITY CURRENT LIABILITIES Accounts payable, accrued $ 500,750 $ 422,029 expenses and other Due to 96,065 70,104 affiliates Deferred 16,116 7,272 revenue Current operating 70,598 61,934 lease liability Current portion of 31,796 25,424 notes payable Current portion of 1,317 – finance lease Total current 716,642 586,763 liabilities LONG-TERM LIABILITIES Long-term finance 3,951 – lease liability Long-term operating 772,771 707,001 lease liability Notes payable, net 1,293,505 1,064,495 of current portion Deferred tax liability, 46,457 21,903 net Other non-current 10,193 22,515 liabilities Total 2,843,519 2,402,677 liabilities EQUITY RadNet, Inc. stockholder… equity: Common stock - $0.0001 par value, 200,000,000 shares authorized; 78,768,800 and 77,399,615 8 8 shares issued and outstanding at September 30, 2026 and December 31, 2025, respectively Additional 1,246,319 1,180,434 paid-in-cap… Accumulated other comprehensi… (7,811 ) 4,885 (loss) income Accumulated (117,220 ) (95,437 ) deficit Total RadNet, Inc.'s 1,121,296 1,089,890 Stockholder… equity:

CASH FLOWS FROM Nine Months Ended OPERATING September 30, ACTIVITIES 2026 2025 ────────────────────────────────────────────────────────────────────────────── Net income $ 14,673 $ 7,186 Adjustments to reconcile net income to net cash provided by operating activities: Depreciation and 137,506 111,275 amortization Noncash operating 49,425 44,605 lease expense Equity in earnings of joint ventures, (4,244 ) (4,590 ) net of dividends Amortization of deferred financing 2,355 2,242 costs and loan discount Loss on sale and disposal of 9,067 3,168 equipment Loss on extinguishment of 407 – debt Gain on contribution of (7,528 ) – imaging centers into joint venture Lease abandonment 3,358 8,330 charges Amortization of – 2,273 cash flow hedge Non-cash change in fair value of – 6,433 interest rate swap Stock-based 51,933 46,276 compensation Change in fair value of 7,864 – contingent consideration Changes in operating assets and liabilities, net of assets acquired and liabilities assumed in purchase transactions:

Accounts (30,461 ) (20,476 ) receivable Other current (4,292 ) 2,093 assets Other assets (7,478 ) (2,764 ) Deferred taxes 4,334 2 Operating leases (45,252 ) (48,760 ) Deferred revenue 581 3,934 Accounts payable, accrued expenses 81,393 53,429 and other Net cash provided by operating 263,641 214,656 activities CASH FLOWS FROM INVESTING ACTIVITIES Purchase of imaging facilities and other (315,708 ) (66,464 ) acquisitions, net of cash acquired Purchase of property and (181,721 ) (162,221 ) equipment and other Proceeds from sale 1,270 75 of equipment Equity contributions in existing and – (4,147 ) purchase of interest in joint ventures Collection of 8,541 2,832 notes receivable Net cash used in investing (487,618 ) (229,925 ) activities CASH FLOWS FROM FINANCING ACTIVITIES Principal payments on notes and (13,993 ) (5,229 ) leases payable Payments on Term (17,028 ) (15,504 ) Loan Debt Proceeds from issuance of new 248,937 99,001 debt, net of issuing costs Purchase of noncontrolling – 2,389 interests by third party Payments on contingent (2,198 ) – consideration and holdbacks Distributions paid to noncontrolling (8,362 ) (3,313 ) interests Proceeds from issuance of common stock 2,517 2,258 upon exercise of options Net cash provided by financing 209,873 79,602 activities EFFECT OF EXCHANGE RATE CHANGES ON (2,504 ) 363 CASH NET (DECREASE) INCREASE IN CASH (16,608 ) 64,696 AND CASH EQUIVALENTS CASH AND CASH EQUIVALENTS, 767,215 740,020 beginning of period CASH AND CASH EQUIVALENTS, end 750,607 804,716 of period SUPPLEMENTAL DISCLOSURE OF CASH FLOW INFORMATION Cash paid during the period for $ 53,635 $ 53,679 interest Cash paid during the period for $ 3,908 $ 3,480 income taxes

RECONCILIATION OF GAAP NET INCOME ATTRIBUTABLE TO RADNET, INC. COMMON SHAREHOLDERS TO ADJUSTED EBITDA

Third Quarter 2026 Commercial Insurance 56.4% Medicare 24.8% Capitation 4.9% Medicaid 2.3% Workers Compensation/Personal Injury 2.1% Other* 9.5% Total 100.0%

* Includes management fee, teleradiology and Digital Health financial reporting unit revenue. RADNET PAYMENTS BY MODALITY

Three Months Ended 2026 September 30, 2025(iv) September 30, ────────────────────────────────────────────────────────────────────────────── NET INCOME (LOSS) ATTRIBUTABLE TO $ 4,153 $ 5,417 RADNET, INC.COMMON STOCKHOLDERS Non-cash impact of – 2,587 cash flow hedges (i) Severance 1,194 1,441 costs Loss (gain) on contribution of imaging (7,528 ) – centers into joint ventures Non-operatio… rent expenses 604 621 (iii) Loss (gain) on sale and disposal of 5,359 1,042 equipment and other Intangibles Amortization Expense - Digital 7,260 3,353 Health Operating Segment Non-capitali… R&D - DeepHealth 5,565 5,486 cloud OS & generative AI Legal 2,815 – Settlement Acquisition transaction 2,708 2,136 costs Non-cash change to 8,257 – contingent consideration Lease abandonment 2,052 2,819 charges Total adjustments - 28,286 19.485 loss (gain) Subtract tax impact of (8,596 ) (6,138 Adjustments (ii) Tax effected impact of 19,690 13,347 adjustments TOTAL ADJUSTMENT TO NET INCOME ATTRIBUTABLE 19,690 13,347 TO RADNET, INC. COMMON SHAREHOLDERS ADJUSTED NET INCOME (LOSS) ATTRIBUTABLE 23,843 18,764 TO RADNET, INC. COMMON STOCKHOLDERS WEIGHTED AVERAGE SHARES OUTSTANDING Diluted 79,174,226 77,388,477 ADJUSTED DILUTED NET INCOME PER SHARE $ 0.30 $ 0.24 ATTRIBUTABLE TO RADNET, INC. COMMON STOCKHOLDERS

Impact is the sum of (a) the loss in fair value of the hedges during the quarter of $2,371 in 2025 and (b) the amortization of the (i) accumulation of the changes in fair value out of Other Comprehensive Income that existed prior to the hedges becoming ineffective of $216 in 2025. (ii) Tax effected using 31.5% blended federal and state effective tax rate for 2025 and 30.4% for 2026. Represents rent expense associated with de novo sites under (iii) construction prior to them becoming operational. Adjusted from what was reported during last year's third quarter for additional addbacks of (a) $1,042,000 related to Loss (gain) on (iv) sale and disposal of equipment and other and (b) Intangible amortization expense of the Digital Health operating segment of $3,353,000.

The Company defines Adjusted EBITDA as earnings before interest, taxes, depreciation and amortization, each from continuing operations and adjusted for losses or gains on the sale of equipment, other income or loss, debt extinguishments and non-cash equity compensation. Adjusted EBITDA includes equity earnings in unconsolidated operations and subtracts allocations of earnings to non- controlling interests in subsidiaries, and is adjusted for non-cash or extraordinary and one-time events taken place during the period.

Adjusted EBITDA is reconciled to its nearest comparable GAAP financial measure. Adjusted EBITDA is a non-GAAP financial measure used as analytical indicator by RadNet management and the healthcare industry to assess business performance, and is a measure of leverage capacity and ability to service debt. Adjusted EBITDA should not be considered a measure of financial performance under GAAP, and the items excluded from Adjusted EBITDA should not be considered in isolation or as alternatives to net income, cash flows generated by operating, investing or financing activities or other financial statement data presented in the consolidated financial statements as an indicator of financial performance or liquidity. As Adjusted EBITDA is not a measurement determined in accordance with GAAP and is therefore susceptible to varying methods of calculation, this metric, as presented, may not be comparable to other similarly titled measures of other companies.

As noted above, the Company defines Free Cash Flow as Adjusted EBITDA less total Capital Expenditures (whether completed with cash or financed) and Cash Interest Expense. Free Cash Flow is a non-GAAP financial measure. The Company uses Free Cash Flow because the Company believes it provides useful information for investors and management because it measures our capacity to generate cash from our operating activities. Free Cash Flow does not represent total cash flow since it does not include the cash flows generated by or used in financing activities. In addition, our definition of Free Cash Flow may differ from definitions used by other companies.

Free Cash Flow should not be considered a measure of financial performance under GAAP, and the items excluded from Adjusted EBITDA should not be considered in isolation or as alternatives to net income, cash flows generated by operating, investing or financing activities or other financial statement data presented in the consolidated financial statements as an indicator of financial performance or liquidity. As Adjusted EBITDA is not a measurement determined in accordance with GAAP and is therefore susceptible to varying methods of calculation, this metric, as presented, may not be comparable to other similarly titled measures of other companies.

The Company defines Adjusted Earnings (Loss) Per Share as net income or loss attributable to RadNet, Inc. common stockholders and excludes losses or gains on the disposal of equipment, loss on debt extinguishments, bargain purchase gains, severance costs, loss on impairment, loss or gain on swap valuation, gain on extinguishment of debt, unusual or non-recurring entries that impact the Company’s tax provision and any other non-recurring or unusual transactions recorded during the period.

Adjusted Earnings (Loss) Per Share is reconciled to its nearest comparable GAAP financial measure. Adjusted Earnings (Loss) Per Share is a non-GAAP financial measure used as analytical indicator by RadNet management and the healthcare industry to assess business performance. Adjusted Earnings Per Share should not be considered a measure of financial performance under GAAP, and the items excluded from Adjusted Earnings Per Share should not be considered in isolation or as alternatives to net income, cash flows generated by operating, investing or financing activities or other financial statement data presented in the consolidated financial statements as an indicator of financial performance or liquidity. As Adjusted Earnings Per Share is not a measurement determined in accordance with GAAP and is therefore susceptible to varying methods of calculation, this metric, as presented, may not be comparable to other similarly titled measures of other companies.

Full text with the tables
                                                                    Exhibit 99.1
FOR IMMEDIATE RELEASE
RadNet Reports Third Quarter Financial Results with Record Quarterly Revenue and
Adjusted EBITDA (1)and Revises Upwards 2026 Financial Guidance Ranges
                                                                                
     Total Company Revenue increased 22.1% to $638.3 million in the third       
     quarter                                                                    
  ·  of 2026 from $522.9 million in the third quarter of 2025; Revenue from     
     the Digital Health reportable segment (inclusive of intersegment           
     revenue) increased 32.6% to $32.9 million in the third quarter of 2026     
     from $24.8 million in the third quarter of 2025                            
     Total Company Adjusted EBITDA(1) was $105.0 million in the                 
     third quarter of 2026 as compared with $84.9 million in the third quarter  
  ·  of 2025, an increase of 23.8%; Digital Health reportable segment           
     Adjusted EBITDA(1) decreased 11.8% to $3.0 million in the third quarter    
     of 2026 from $3.5 million in the third quarter of 2025                     
     Total Company Adjusted EBITDA(1) margin increased to 16.5%                 
  ·  in the third quarter of 2026 as compared with 16.2% in the third quarter   
     of 2025                                                                    
     Adjusting for unusual or one-time items in the quarter, Adjusted Diluted   
  ·  Earnings Per Share(3) was $0.30 for the third quarter of 2026; This        
     compares with Adjusted Diluted Earnings Per Share(3)                       
     of $0.24 for the third quarter of 2025                                     
     In the third quarter of 2026, aggregate advanced imaging (MRI, CT and      
  ·  PET/CT) procedural volumes increased 19.9% and same-center advanced        
     imaging procedural volumes increased 8.9% as compared with the third       
     quarter of 2025                                                            
  ·  As of September 30, 2026, we had a cash balance of $750.6 million and      
     Net Debt to Adjusted EBITDA(1) ratio of 1.66x                              
  ·  RadNet revises full-year 2026 guidance levels to increase Imaging Center   
     Revenue, Adjusted EBITDA(1)and Free Cash Flow(2) ranges                    
                                                                                
LOS ANGELES, California, November 8, 2026 – RadNet, Inc. (NASDAQ: RDNT), a
national leader in providing high-quality, cost-effective outpatient diagnostic
imaging services and
a premier global developer of digital health solutions, today reported financial
results for its third quarter of 2026.

Dr. Howard Berger, President and Chief Executive
Officer of RadNet, commented, “We delivered record quarterly Revenue and
Adjusted EBITDA in the third quarter. Total
Company Revenue grew 22.1% and Adjusted EBITDA grew 23.8% compared with last
year’s third quarter, and Adjusted EBITDA
margin expanded 23 basis points. These results were driven by continued
initiatives to create and fill capacity at existing imaging centers,
new center openings, the continued shift in the business mix towards advanced
imaging, tuck-in acquisitions, improved reimbursement from
commercial payors, the expansion of our health system joint ventures and 32.6%
Revenue growth in the Digital Health segment.”
     
  1  
     
Dr. Berger continued, “Advanced imaging
growth continues to be strong, both in aggregate and on a same-center basis.
Compared with last year’s third quarter, aggregate
advanced imaging procedural volumes increased 19.9% and same-center advanced
imaging procedural volumes increased 8.9%. As a result, RadNet’s
advanced imaging business mix increased 232 basis points, from 28.2% of all
procedures in the third quarter of 2025 to 30.6% in the third
quarter of 2026.”

“With strong performance across nearly every
part of the core imaging center business, we are again raising certain guidance
ranges in anticipation that full-year results will exceed
both our original expectations and the revised ranges issued in conjunction with
first and second quarter 2026 results. We are raising
2026 Imaging Center guidance ranges for Revenue, Adjusted EBITDA and Free Cash
Flow,” added Dr. Berger.

Dr. Berger continued, “We are particularly
excited about the opportunities for growth and expansion that will be made
possible as a result of the recently announced pending acquisition
of ONRAD. The inbound interest from current joint venture partners and potential
new partners and customers has exceeded our expectations.
The strategic fit that ONRAD’s capabilities have with both RadNet’s core imaging
center business and Digital Health solutions
is already being recognized in the imaging marketplace, and we look forward to
the opportunities that could result once the acquisition
is closed.”

“RadNet’s balance sheet remains healthy
and continues to provide the operating flexibility necessary to achieve further
growth. We ended the third quarter with $750.6 million
in cash and a Net Debt to Adjusted EBITDA leverage ratio of 1.66x. This
liquidity enables us to keep investing in organic
growth and to pursue attractive strategic acquisitions in the coming quarters,”
concluded Dr. Berger.
     
  2  
     
Third Quarter Financial Results

For the third quarter of 2026, RadNet reported
Total Company Revenue of $638.3 million and Adjusted EBITDA of $105.0 million.
Revenue increased $115.4 million (or 22.1%)
and Adjusted EBITDA increased $20.2 million (or 23.8%) as compared with the
third quarter of 2025.

For the third quarter of 2026, RadNet reported
Digital Health Revenue (inclusive of intersegment revenue) of $32.9 million and
Adjusted EBITDA of $3.0 million. Revenue
increased $8.1 million (or 32.6%) and Adjusted EBITDA decreased $0.4 million (or
-11.8%) as compared with the third quarter
of 2025.

Unadjusted for unusual or one-time items impacting
the third quarter, Total Company Net Income for the third quarter of 2026 was
$4.2 million as compared with a Total Company Net Income
of $5.4 million for the third quarter of 2025. Fully diluted Net Income Per
Share for the third quarter of 2026 was $0.05, compared with
a fully diluted Net Income Per Share of $0.07 in the third quarter of 2025,
based upon a weighted average number of diluted shares outstanding
of 79.2 million shares in the third quarter of 2026 and 77.4 million shares in
the third quarter of 2025.

There were a number of unusual, one-time and noteworthy
items impacting the third quarter including: $1.2 million in severance expense
related to cost-savings initiatives; $7.5 million gain
on the contribution of imaging centers into joint ventures; $0.6 million expense
related to leases for de novo facilities under construction
that have yet to open their operations; $5.4 million loss on the disposal of
equipment; $7.3 million intangibles amortization expense
related to the Digital Health operating segment; $5.6 million of non-capitalized
research and development expenses related to the DeepHealth
Cloud OS and AI solutions; $2.8 million in legal settlements; $2.7 million of
acquisition transaction costs; $8.3 million in non-cash
change in contingent consideration; and $2.1 million of lease abandonment
charges. Adjusting for the above items, Total Company Adjusted
Earnings was $23.8 million and diluted Adjusted Earnings Per Share was $0.30
during the third quarter of 2026.
This compares with Total Company Adjusted Earnings of $18.8 million and diluted
Adjusted Earnings Per Share
of $0.24 during the third quarter of 2025.

For the third quarter of 2026, as compared with
the prior year’s third quarter, MRI volume increased 18.3%, CT volume increased
22.0% and PET/CT volume increased 30.4%. Overall
volume, taking into account routine imaging exams, inclusive of x-ray,
ultrasound, mammography and other exams, increased 10.8% over the
prior year’s third quarter. On a same-center basis, including only those centers
which were part of RadNet for both the third quarters
of 2026 and 2025, MRI volume increased 8.2%, CT volume increased 10.2% and
PET/CT volume increased 8.2%. Overall same-center volume, taking
into account routine imaging exams, inclusive of x-ray, ultrasound, mammography
and other exams, increased 3.2% over the prior year’s
same quarter

Nine Month Financial Results

For the first nine months of 2026, RadNet reported
Total Company Revenue of $1,836.6 million and Adjusted EBITDA of $268.0 million.
Revenue increased $344.1 million (or 23.1%)
and Adjusted EBITDA increased $55.4 million (or 26.1%) as compared with the
first nine months of 2025.

For the first nine months of 2026, RadNet reported
Digital Health Revenue (inclusive of intersegment revenue) of $94.5 million and
Adjusted EBITDA of $6.8 million. Revenue
increased $29.7 million (or 45.8%) and Adjusted EBITDA decreased $3.7 million
(or -35.4%) as compared with the first nine
months of 2025.

Unadjusted for one-time or unusual items, Total
Company Net Loss for the first nine months of 2026 was $21.8 million as compared
with a Total Company Net Loss of $18.1 million for the
first nine months of 2025. Fully diluted Net Loss Per Share for the nine month
period of 2026 was $(0.28), compared with a fully diluted
Net Loss Per Share of $(0.24) in the nine month period of 2025, based upon a
weighted average number of diluted shares outstanding of
77.6 million shares for the nine month period in 2026 and 74.7 million shares
for the nine month period in 2025.
     
  3  
     
2026 Guidance Update

RadNet amends its previously announced guidance
levels as follows:
                                                                                
                                 Revised         Revised          Revised       
                 Original        Guidance        Guidance         Guidance      
                 Guidance        Range           Range After      Range After   
                 Range           After Q1        Q2 Results       Q3 Results    
                                 Results                                        
  Total Net      $2,325 -        $2,355 -        $2,370 -         $2,385 -      
  Revenue        $2,375          $2,405          $2,420           $2,435        
                 million         million         million          million       
  Adjusted       $335 - $348     $340 - $353     $345 - $358      $350 - $363   
  EBITDA(1)      million         million         million          million       
  Capital        $165 - $175     $165 - $175     $165 - $175      $170 - $180   
  Expenditur…    million         million         million          million       
  Cash           $45 - $50       $45 - $50       $48 - $53        $48 - $53     
  Interest       million         million         million          million       
  Expense(b)                                                                    
  Free Cash      $105 - $115     $112 - $122     $115 - $125      $120 - $130   
  Flow (2)       million         million         million          million       
                                                                                
                                                                                
       Net of proceeds from the sale of equipment and the New Jersey Imaging    
  (a)  Network L.L.C. joint venture capital                                     
       expenditures.                                                            
                                                                                
                                                                                
       Net of payments received from counterparties on interest rate swaps and  
  (b)  interest income from our cash                                            
       balance recorded in Other Income.                                        
                                                                                
                                                                                
                                 Revised         Revised          Revised       
                 Original        Guidance        Guidance         Guidance      
                 Guidance        Range After     Range After      Range After   
                 Range           Q1              Q2               Q3            
                                 Results         Results          Results       
  Total Net                                                                     
  Revenue        $135                                                           
  (inclusive     - $145          $135 - $145     $135 - $145      $135 - $145   
  of             million         million         million          million       
  intersegme…                                                                   
  revenue)                                                                      
  Adjusted                                                                      
  EBITDA(1)                                                                     
  Before                                                                        
  Non-Capita…    $10 - $12       $10 - $12       $10 - $12        $11 - $13     
  R&D -          million         million         million          million       
  DeepHealth                                                                    
  Cloud OS &                                                                    
  Generative                                                                    
  AI                                                                            
  Non-Capita…                                                                   
  R&D -                                                                         
  DeepHealth     $17 - $19       $17 - $19       $17 - $19        $17 - $19     
  Cloud          million         million         million          million       
  OS &                                                                          
  Generative                                                                    
  AI                                                                            
  Capital        $9 - $12        $9 - $12        $9 - $12         $10 - $13     
  Expenditur…    million         million         million          million       
  Free Cash                                                                     
  Flow(2)                                                                       
  Before                                                                        
  Non-Capita…    $(1) - $3       $(1) - $3       $(1) - $3        $(1) - $3     
  R&D -          million         million         million          million       
  DeepHealth                                                                    
  Cloud OS &                                                                    
  Generative                                                                    
  AI                                                                            
  Free Cash                                                                     
  Flow(2)                                                                       
  After                                                                         
  Non-Capita…    $(17) -         $(17) -         $(17) - $(19)    $(17) -       
  R&D -          $(19)           $(19)           million          $(19)         
  DeepHealth     million         million                          million       
  Cloud OS &                                                                    
  Generative                                                                    
  AI                                                                            
                                                                                
Dr. Berger explained, “The Imaging Center
segment has outperformed projections in each of the first three quarters of this
year. As a result, we are raising its guidance ranges
for Revenue, Adjusted EBITDA and Free Cash Flow. In the Digital Health segment,
we are raising the Adjusted
EBITDA guidance range as a result of effective expense management and faster-
than-projected integration of acquired operations.”
     
  4  
     
Conference Call for Tomorrow

Dr. Howard Berger, President and Chief Executive
Officer, and Mark Stolper, Executive Vice President and Chief Financial Officer,
will host a conference call to discuss its third quarter
2026 results on Monday, November 9th, 2026 at 7:30 a.m. Pacific Time (10:30 a.m.
Eastern Time).

Conference Call Details:

Date: Monday, November 9, 2026

Time: 10:30 a.m. Eastern Time

Dial In-Number: 844-744-1280

International Dial-In Number: 412-564-6465

It is recommended that participants dial in approximately 5 minutes prior to the
start of the 10:30 a.m. call. There will also be simultaneous and archived
webcasts available
athttps://viavid.webcasts.com/starthere.jsp?ei=1780998&tp_key=f33fc0e8e8
or http://www.radnet.com under the “Investors” menu section and “News Releases”
sub-menu of the website. An archived replay of the call will also be available
and can be accessed by dialing 844-512-2921 from the U.S., or 412-317-6671 for
international callers, and using the passcode 10213035.

About RadNet, Inc.

RadNet, Inc. is a leading national provider of
freestanding, fixed-site diagnostic imaging services in the United States based
on the number of locations and annual imaging revenue.
RadNet has a network of owned and/or operated outpatient imaging centers.
RadNet’s imaging center markets include Arizona, California,
Delaware, Florida, Idaho, Indiana, Maryland, New Jersey, New York, Texas and
Virginia. In addition, RadNet provides radiology information
technology and artificial intelligence solutions marketed under the DeepHealth
brand, teleradiology professional services and other related
products and services to customers in the diagnostic imaging industry globally.
Together with contracted radiologists, and inclusive of
full-time and per diem employees and technologists, RadNet has over 12,000 team
members. Learn more at www.radnet.com.
     
  5  
     
Forward Looking Statements

This press release contains “forward-looking
statements” within the meaning of the safe harbor provisions of the U.S. Private
Securities Litigation Reform Act of 1995. Forward-looking
statements are expressions of our current beliefs, expectations and assumptions
regarding the future of our business, future plans and
strategies, projections, and anticipated future conditions, events and trends.
Forward-looking statements can generally be identified
by words such as: “anticipate,” “intend,” “plan,” “goal,” “seek,” “believe,”
“project,” “estimate,” “expect,” “strategy,” “future,” “likely,”
“may,” “should,” “will” and similar references to future periods. Forward-
looking statements in this
press release include, among others, statements about our anticipated business
results, balance sheet and liquidity and our future liquidity,
burn rate and our continuing ability to service or refinance our current
indebtedness.

Forward-looking statements are neither historical
facts nor assurances of future performance. Because forward-looking statements
relate to the future, they are inherently subject to uncertainties,
risks and changes in circumstances that are difficult to predict and many of
which are outside of our control. Our actual results and
financial condition may differ materially from those indicated in the forward-
looking statements. Therefore, you should not place undue
reliance on any of these forward-looking statements. Important factors that
could cause our actual results and financial condition to
differ materially from those indicated in the forward-looking statements
include, among others, the following:
                                                                                
  ·  the availability and terms of capital to fund                              
     our business;                                                              
     our ability to service our indebtedness, make                              
  ·  principal and interest payments as those payments become due and remain    
     in compliance with applicable debt covenants, in addition to our           
     ability to refinance such indebtedness on acceptable terms;                
  ·  changes in general economic conditions nationally                          
     and regionally in the markets in which we operate;                         
     the availability and terms of capital to fund                              
  ·  the expansion of our business and improvements to our existing             
     facilities;                                                                
     our ability to maintain our current credit rating                          
  ·  and the impact on our funding costs and competitive position if we do not  
     do so;                                                                     
     our ability to acquire, develop, implement and monetize technology,        
  ·  digital health initiatives, artificial                                     
     intelligence algorithms and applications;                                  
  ·  volatility in interest and exchange rates, or                              
     credit markets;                                                            
  ·  the adequacy of our cash flow and earnings to                              
     fund our current and future operations;                                    
  ·  changes in service mix, revenue mix and procedure                          
     volumes;                                                                   
  ·  delays in receiving payments for services provided;                        
  ·  increased bankruptcies among our partner physicians                        
     or joint venture partners;                                                 
     the impact of the political environment and related                        
  ·  developments on the current healthcare marketplace and on our business,    
     including with respect to the future of the Affordable Care Act;           
     the extent to which the ongoing implementation                             
     of healthcare reform, or changes in or new legislation, regulations or     
  ·  guidance, enforcement thereof by federal and state regulators or           
     related litigation result in a reduction in coverage or reimbursement      
     rates for our services, or other material impacts to our business;         
     closures or slowdowns and changes in labor costs                           
  ·  and labor difficulties, including stoppages affecting either our           
     operations or our suppliers' abilities to deliver supplies needed in       
     our facilities;                                                            
  ·  the occurrence of hostilities, political instability                       
     or catastrophic events;                                                    
  ·  the emergence or reemergence of and effects related                        
     to future pandemics, epidemics and infectious diseases; and                
     noncompliance by us with any privacy or security                           
  ·  laws or any cybersecurity incident or other security breach by us or a     
     third party involving the misappropriation, loss or other unauthorized     
     use or disclosure of confidential information.                             
                                                                                
Any forward-looking statement contained in this
current report is based on information currently available to us and speaks only
as of the date on which it is made. We undertake no obligation
to publicly update any forward-looking statement, whether written or oral, that
we may make from time to time, whether as a result of
changed circumstances, new information, future developments or otherwise, except
as required by applicable law.
     
  6  
     
Regulation G: GAAP and Non-GAAP Financial Information

This release contains certain financial information
not reported in accordance with GAAP. The Company uses both GAAP and non-GAAP
metrics to measure its financial results. The Company believes
that, in addition to GAAP metrics, these non-GAAP metrics assist the Company in
measuring its cash-based performance. The Company believes
this information is useful to investors and other interested parties because it
removes unusual and nonrecurring charges that occur in
the affected period and provides a basis for measuring the Company's financial
condition against other quarters. Such information should
not be considered as a substitute for any measures calculated in accordance with
GAAP, and may not be comparable to other similarly titled
measures of other companies. Non-GAAP financial measures should not be
considered in isolation from, or as a substitute for, financial
information prepared in accordance with GAAP. Reconciliation of this information
to the most comparable GAAP measures is included in this
release in the tables which follow.

CONTACTS:

RadNet, Inc.

Mark Stolper, 310-445-2800

Executive Vice President and Chief Financial Officer
     
  7  
     
                         RADNET, INC. AND SUBSIDIARIES                          
                                                                                
                     CONDENSED CONSOLIDATED BALANCE SHEETS                      
                                                                                
                 (IN THOUSANDS EXCEPT SHARE AND PER SHARE DATA)                 
                                                                                
                  September 30,                   December 31,                  
                  2026                            2025                          
 ────────────────────────────────────────────────────────────────────────────── 
                                 -unaudited                                     
  ASSETS                                                                        
  CURRENT                                                                       
  ASSETS                                                                        
  Cash and                                                                      
  Cash            $                 750,607       $                 767,215     
  equivalents                                                                   
  Accounts                          248,893                         200,317     
  receivable                                                                    
  Due from                            5,600                          12,592     
  affiliates                                                                    
  Prepaid                                                                       
  expenses and                                                                  
  other                              63,341                          52,003     
  current                                                                       
  assets                                                                        
  Total                                                                         
  current                         1,068,441                       1,032,127     
  assets                                                                        
  PROPERTY,                                                                     
  EQUIPMENT                                                                     
  AND                                                                           
  RIGHT-OF-USE                                                                  
  ASSETS                                                                        
  Property and                                                                  
  equipment,                        904,274                         807,702     
  net                                                                           
  Operating                                                                     
  lease                             755,606                         690,250     
  right-of-use                                                                  
  assets                                                                        
  Total                                                                         
  property,                                                                     
  equipment                       1,659,880                       1,497,952     
  and                                                                           
  right-of-use                                                                  
  assets                                                                        
  OTHER ASSETS                                                                  
  Goodwill                        1,136,986                         907,663     
  Other                                                                         
  intangible                        235,063                         148,508     
  assets                                                                        
  Deferred                                                                      
  financing                           1,248                           1,684     
  costs                                                                         
  Investment                                                                    
  in joint                          131,507                         130,340     
  ventures                                                                      
  Deposits and                       47,273                          40,289     
  other                                                                         
  Total Assets    $               4,280,398       $               3,758,563     
  LIABILITIES                                                                   
  AND EQUITY                                                                    
  CURRENT                                                                       
  LIABILITIES                                                                   
  Accounts                                                                      
  payable,                                                                      
  accrued         $                 500,750       $                 422,029     
  expenses and                                                                  
  other                                                                         
  Due to                             96,065                          70,104     
  affiliates                                                                    
  Deferred                           16,116                           7,272     
  revenue                                                                       
  Current                                                                       
  operating                          70,598                          61,934     
  lease                                                                         
  liability                                                                     
  Current                                                                       
  portion of                         31,796                          25,424     
  notes                                                                         
  payable                                                                       
  Current                                                                       
  portion of                          1,317                               –     
  finance                                                                       
  lease                                                                         
  Total                                                                         
  current                           716,642                         586,763     
  liabilities                                                                   
  LONG-TERM                                                                     
  LIABILITIES                                                                   
  Long-term                                                                     
  finance                             3,951                               –     
  lease                                                                         
  liability                                                                     
  Long-term                                                                     
  operating                         772,771                         707,001     
  lease                                                                         
  liability                                                                     
  Notes                                                                         
  payable, net                    1,293,505                       1,064,495     
  of current                                                                    
  portion                                                                       
  Deferred tax                                                                  
  liability,                         46,457                          21,903     
  net                                                                           
  Other                                                                         
  non-current                        10,193                          22,515     
  liabilities                                                                   
  Total                           2,843,519                       2,402,677     
  liabilities                                                                   
  EQUITY                                                                        
  RadNet, Inc.                                                                  
  stockholder…                                                                  
  equity:                                                                       
  Common stock                                                                  
  - $0.0001                                                                     
  par value,                                                                    
  200,000,000                                                                   
  shares                                                                        
  authorized;                                                                   
  78,768,800                                                                    
  and                                                                           
  77,399,615                              8                               8     
  shares                                                                        
  issued                                                                        
  and                                                                           
  outstanding                                                                   
  at September                                                                  
  30, 2026                                                                      
  and December                                                                  
  31, 2025,                                                                     
  respectively                                                                  
  Additional                      1,246,319                       1,180,434     
  paid-in-cap…                                                                  
  Accumulated                                                                   
  other                                                                         
  comprehensi…                       (7,811  )                        4,885     
  (loss)                                                                        
  income                                                                        
  Accumulated                      (117,220  )                      (95,437  )  
  deficit                                                                       
  Total                                                                         
  RadNet,                                                                       
  Inc.'s                          1,121,296                       1,089,890     
  Stockholder…                                                                  
  equity:                                                                       
                                                                                
  Noncontroll…                      315,583                         265,996     
  interests                                                                     
  Total Equity                    1,436,879                       1,355,886     
  Total                                                                         
  liabilities     $               4,280,398       $               3,758,563     
  and equity                                                                    
                                                                                
     
  8  
     
                         RADNET, INC. AND SUBSIDIARIES                          
                                                                                
                 CONDENSED CONSOLIDATED STATEMENT OF OPERATIONS                 
                                                                                
               (IN THOUSANDS EXCEPT FOR SHARE AND PER SHARE DATA)               
                                                                                
                                  (unaudited)                                   
                                                                                
          Three                               Nine                              
          Mont…                               Mont…                             
          Ended                               Ended                             
          Sept…                               Sept…                             
          30,                                 30,                               
  REV…    2026               2025             2026              2025            
 ────────────────────────────────────────────────────────────────────────────── 
  Ser…                                                                          
  fee     $      607,…       $     491…       $      1,7…       $     1,39…     
  rev…                                                                          
  Rev…                                                                          
  und…           31,2…             31,…              91,…             93,6…     
  cap…                                                                          
  arr…                                                                          
  Tot…                                                                          
  ser…           638,…             522…              1,8…             1,49…     
  rev…                                                                          
  OPE…                                                                          
  EXP…                                                                          
  Cost                                                                          
  of                                                                            
  ope…                                                                          
  exc…           552,…             450…              1,6…             1,33…     
  dep…                                                                          
  and                                                                           
  amo…                                                                          
  Lea…                                                                          
  aba…           2,052             2,8…              3,3…             8,330     
  cha…                                                                          
  Dep…                                                                          
  and            47,0…             39,…              137…             111,…     
  amo…                                                                          
  Loss                                                                          
  (ga…                                                                          
  on                                                                            
  sale                                                                          
  and            5,359             1,0…              9,0…             3,168     
  dis…                                                                          
  of                                                                            
  equ…                                                                          
  and                                                                           
  oth…                                                                          
  Sev…           1,193             1,4…              3,3…             2,614     
  cos…                                                                          
  Tot…                                                                          
  ope…           607,…             495…              1,7…             1,45…     
  exp…                                                                          
  INC…                                                                          
  (LO…           30,2…             27,…              45,…             34,1…     
  FROM                                                                          
  OPE…                                                                          
  OTH…                                                                          
  INC…                                                                          
  AND                                                                           
  EXP…                                                                          
  Int…           20,6…             17,…              56,…             51,7…     
  exp…                                                                          
  Equ…                                                                          
  in                                                                            
  ear…           (4,2…  )          (3,…  )           (12…  )          (10,…  )  
  of                                                                            
  joi…                                                                          
  ven…                                                                          
  Non…                                                                          
  cha…                                                                          
  in                                                                            
  fair                                                                          
  val…               –             2,3…                 –             6,433     
  of                                                                            
  int…                                                                          
  rate                                                                          
  hed…                                                                          
  Debt                                                                          
  res…                                                                          
  and                –                –              3,3…                 –     
  ext…                                                                          
  exp…                                                                          
  Loss                                                                          
  (ga…                                                                          
  on                                                                            
  con…                                                                          
  of             (7,5…  )             –              (7,…  )              –     
  ima…                                                                          
  cen…                                                                          
  into                                                                          
  joi…                                                                          
  ven…                                                                          
  Oth…                                                                          
  (in…           (6,2…  )          (9,…  )           (15…  )          (24,…  )  
  exp…                                                                          
  Tot…                                                                          
  oth…           2,749             7,1…              24,…             23,1…     
  (in…                                                                          
  exp…                                                                          
  INC…                                                                          
  (LO…                                                                          
  BEF…           27,5…             20,…              21,…             10,9…     
  INC…                                                                          
  TAX…                                                                          
  Pro…                                                                          
  for            (8,3…  )          (6,…  )           (6,…  )          (3,8…  )  
  inc…                                                                          
  tax…                                                                          
  NET                                                                           
  INC…           19,1…             13,…              14,…             7,186     
  (LO…                                                                          
  Net                                                                           
  inc…                                                                          
  (lo…                                                                          
  att…           14,9…             8,4…              36,…             25,2…     
  to                                                                            
  non…                                                                          
  int…                                                                          
  NET                                                                           
  INC…                                                                          
  (LO…                                                                          
  ATT…                                                                          
  TO      $      4,153       $     5,4…       $      (21…  )    $     (18,…  )  
  RAD…                                                                          
  INC.                                                                          
  COM…                                                                          
  STO…                                                                          
  BAS…                                                                          
  NET                                                                           
  INC…                                                                          
  (LO…                                                                          
  PER                                                                           
  SHA…    $       0.05       $     0.07       $      (0.…  )    $     (0.24  )  
  ATT…                                                                          
  TO                                                                            
  RAD…                                                                          
  INC.                                                                          
  COM…                                                                          
  STO…                                                                          
  DIL…                                                                          
  NET                                                                           
  INC…                                                                          
  (LO…                                                                          
  PER                                                                           
  SHA…    $       0.05       $     0.07       $      (0.…  )    $     (0.24  )  
  ATT…                                                                          
  TO                                                                            
  RAD…                                                                          
  INC.                                                                          
  COM…                                                                          
  STO…                                                                          
  WEI…                                                                          
  AVE…                                                                          
  SHA…                                                                          
  OUT…                                                                          
  Bas…           77,9…             75,…              77,…             74,7…     
  Dil…           79,1…             77,…              77,…             74,7…     
                                                                                
     
  9  
     
                         RADNET, INC. AND SUBSIDIARIES                          
                                                                                
                 CONDENSED CONSOLIDATED STATEMENTS OF CASHFLOWS                 
                                                                                
                                 (IN THOUSANDS)                                 
                                                                                
                                  (unaudited)                                   
                                                                                
  CASH FLOWS FROM       Nine Months Ended                                       
  OPERATING             September 30,                                           
  ACTIVITIES            2026                                 2025               
 ────────────────────────────────────────────────────────────────────────────── 
  Net income            $                       14,673       $        7,186     
  Adjustments to                                                                
  reconcile net                                                                 
  income to                                                                     
  net cash provided                                                             
  by operating                                                                  
  activities:                                                                   
  Depreciation and                             137,506              111,275     
  amortization                                                                  
  Noncash operating                             49,425               44,605     
  lease expense                                                                 
  Equity in earnings                                                            
  of joint ventures,                            (4,244  )            (4,590  )  
  net of dividends                                                              
  Amortization of                                                               
  deferred financing                             2,355                2,242     
  costs                                                                         
  and loan discount                                                             
  Loss on sale and                                                              
  disposal of                                    9,067                3,168     
  equipment                                                                     
  Loss on                                                                       
  extinguishment of                                407                    –     
  debt                                                                          
  Gain on                                                                       
  contribution of                               (7,528  )                 –     
  imaging centers                                                               
  into joint venture                                                            
  Lease abandonment                              3,358                8,330     
  charges                                                                       
  Amortization of                                    –                2,273     
  cash flow hedge                                                               
  Non-cash change in                                                            
  fair value of                                      –                6,433     
  interest rate swap                                                            
  Stock-based                                   51,933               46,276     
  compensation                                                                  
  Change in fair                                                                
  value of                                       7,864                    –     
  contingent                                                                    
  consideration                                                                 
  Changes in                                                                    
  operating assets                                                              
  and                                                                           
  liabilities, net                                                              
  of assets acquired                                                            
  and                                                                           
  liabilities                                                                   
  assumed in                                                                    
  purchase                                                                      
  transactions:                                                                 
                                                                                
  Accounts                                     (30,461  )           (20,476  )  
  receivable                                                                    
  Other current                                 (4,292  )             2,093     
  assets                                                                        
  Other assets                                  (7,478  )            (2,764  )  
  Deferred taxes                                 4,334                    2     
  Operating leases                             (45,252  )           (48,760  )  
  Deferred revenue                                 581                3,934     
  Accounts payable,                                                             
  accrued expenses                              81,393               53,429     
  and                                                                           
  other                                                                         
  Net cash provided                                                             
  by operating                                 263,641              214,656     
  activities                                                                    
  CASH FLOWS FROM                                                               
  INVESTING                                                                     
  ACTIVITIES                                                                    
  Purchase of                                                                   
  imaging facilities                                                            
  and other                                   (315,708  )           (66,464  )  
  acquisitions, net                                                             
  of cash acquired                                                              
  Purchase of                                                                   
  property and                                (181,721  )          (162,221  )  
  equipment and                                                                 
  other                                                                         
  Proceeds from sale                             1,270                   75     
  of equipment                                                                  
  Equity                                                                        
  contributions in                                                              
  existing and                                       –               (4,147  )  
  purchase of                                                                   
  interest in joint                                                             
  ventures                                                                      
  Collection of                                  8,541                2,832     
  notes receivable                                                              
  Net cash used in                                                              
  investing                                   (487,618  )          (229,925  )  
  activities                                                                    
  CASH FLOWS FROM                                                               
  FINANCING                                                                     
  ACTIVITIES                                                                    
  Principal payments                                                            
  on notes and                                 (13,993  )            (5,229  )  
  leases                                                                        
  payable                                                                       
  Payments on Term                             (17,028  )           (15,504  )  
  Loan Debt                                                                     
  Proceeds from                                                                 
  issuance of new                              248,937               99,001     
  debt, net                                                                     
  of issuing costs                                                              
  Purchase of                                                                   
  noncontrolling                                     –                2,389     
  interests by                                                                  
  third party                                                                   
  Payments on                                                                   
  contingent                                    (2,198  )                 –     
  consideration and                                                             
  holdbacks                                                                     
  Distributions paid                                                            
  to noncontrolling                             (8,362  )            (3,313  )  
  interests                                                                     
  Proceeds from                                                                 
  issuance of common                                                            
  stock                                          2,517                2,258     
  upon exercise of                                                              
  options                                                                       
  Net cash provided                                                             
  by financing                                 209,873               79,602     
  activities                                                                    
  EFFECT OF EXCHANGE                                                            
  RATE CHANGES ON                               (2,504  )               363     
  CASH                                                                          
  NET (DECREASE)                                                                
  INCREASE IN CASH                             (16,608  )            64,696     
  AND CASH                                                                      
  EQUIVALENTS                                                                   
  CASH AND CASH                                                                 
  EQUIVALENTS,                                 767,215              740,020     
  beginning of                                                                  
  period                                                                        
  CASH AND CASH                                                                 
  EQUIVALENTS, end                             750,607              804,716     
  of period                                                                     
  SUPPLEMENTAL                                                                  
  DISCLOSURE OF CASH                                                            
  FLOW                                                                          
  INFORMATION                                                                   
  Cash paid during                                                              
  the period for        $                       53,635       $       53,679     
  interest                                                                      
  Cash paid during                                                              
  the period for        $                        3,908       $        3,480     
  income                                                                        
  taxes                                                                         
                                                                                
      
  10  
      
                         RADNET, INC. AND SUBSIDIARIES                          
                                                                                
     RECONCILIATION OF GAAP NET INCOME ATTRIBUTABLE TO RADNET, INC. COMMON      
                        SHAREHOLDERS TO ADJUSTED EBITDA                         
                                                                                
                                 (IN THOUSANDS)                                 
                                                                                
                Three                                Nine                       
                Mont…                               Mont…                       
                Ended                               Ended                       
                Sept…                               Sept…                       
          2026    30,       2025              2026    30,       2025            
 ────────────────────────────────────────────────────────────────────────────── 
  Net                                                                           
  inc…                                                                          
  (lo…                                                                          
  att…                                                                          
  to      $     4,153       $     5,417       $     (21,…  )    $     (18,…  )  
  Rad…                                                                          
  Inc.                                                                          
  com…                                                                          
  sto…                                                                          
  Inc…          8,361             6,385             6,628             3,807     
  tax…                                                                          
  Int…          20,6…             17,3…             56,4…             51,7…     
  exp…                                                                          
  Sev…          1,193             1,441             3,317             2,614     
  cos…                                                                          
  Dep…                                                                          
  and           47,0…             39,7…             137,…             111,…     
  amo…                                                                          
  Non…                                                                          
  emp…          10,0…             9,041             51,9…             46,2…     
  sto…                                                                          
  com…                                                                          
  Loss                                                                          
  (ga…                                                                          
  on                                                                            
  sale                                                                          
  and           5,359             1,042             9,067             3,168     
  dis…                                                                          
  of                                                                            
  equ…                                                                          
  and                                                                           
  oth…                                                                          
  Non…                                                                          
  cha…                                                                          
  in                                                                            
  fair                                                                          
  val…              –             2,371                 –             6,433     
  of                                                                            
  int…                                                                          
  rate                                                                          
  hed…                                                                          
  Oth…                                                                          
  exp…          (6,2…  )          (9,0…  )          (15,…  )          (24,…  )  
  (in…                                                                          
  Non…                                                                          
  R&D                                                                           
  -                                                                             
  Dee…          5,565             5,486             15,2…             13,8…     
  Clo…                                                                          
  OS &                                                                          
  Gen…                                                                          
  AI                                                                            
  Lea…                                                                          
  aba…          2,052             2,819             3,358             8,330     
  cha…                                                                          
  Loss                                                                          
  (ga…                                                                          
  on                                                                            
  con…                                                                          
  of            (7,5…  )              –             (7,5…  )              –     
  ima…                                                                          
  cen…                                                                          
  into                                                                          
  joi…                                                                          
  ven…                                                                          
  Loss                                                                          
  (ga…                                                                          
  on                                                                            
  ext…                                                                          
  of                –                 –             3,368                 –     
  debt                                                                          
  and                                                                           
  rel…                                                                          
  exp…                                                                          
  Leg…          2,815                 –             2,815                 –     
  set…                                                                          
  Non…                                                                          
  cha…                                                                          
  to            8,257                 –             7,864                 –     
  con…                                                                          
  con…                                                                          
  Non…                                                                          
  rent            604               621             2,002             2,459     
  exp…                                                                          
  Acq…                                                                          
  tra…          2,708             2,136             12,7…             5,109     
  cos…                                                                          
  Adj…                                                                          
  EBI…                                                                          
  -       $     105,…       $     84,8…       $     267,…       $     212,…     
  Rad…                                                                          
  Inc.                                                                          
  NOTE                                                                          
  Adj…                                                                          
  EBI…                                                                          
  -             101,…             81,4…             261,…             201,…     
  Ima…                                                                          
  Cen…                                                                          
  Seg…                                                                          
  Adj…                                                                          
  EBI…                                                                          
  -             3,046             3,452             6,827             10,5…     
  Dig…                                                                          
  Hea…                                                                          
  Seg…                                                                          
                                                                                
      
  11  
      
                            PAYMENTS BY PAYOR CLASS                             
                                                                 
                                          Third Quarter          
                                                   2026          
  Commercial Insurance                                   56.4%   
  Medicare                                               24.8%   
  Capitation                                             4.9%    
  Medicaid                                               2.3%    
  Workers Compensation/Personal Injury                   2.1%    
  Other*                                                 9.5%    
  Total                                                  100.0%  
                                                                 
* Includes management fee, teleradiology and
Digital Health financial reporting unit revenue.
                          RADNET PAYMENTS BY MODALITY                           
                                                                            
                      Third Quarter    Full Year    Full Year    Full Year  
                               2026         2025         2024         2023  
  MRI                         38.6%        37.7%        37.1%        36.8%  
  CT                          15.4%        15.6%        15.9%        16.8%  
  PET/CT                      10.2%         8.8%         7.2%         6.4%  
  X-ray                        4.9%         5.5%         6.0%         6.5%  
  Ultrasound                  13.4%        13.5%        13.6%        12.9%  
  Mammography                 14.1%        15.6%        16.4%        16.0%  
  Nuclear Medicine             0.8%         0.9%         1.0%         0.8%  
  Other                        2.6%         2.5%         2.7%         3.9%  
                             100.0%       100.0%       100.0%       100.0%  
                                                                            
                            PROCEDURES BY MODALITY*                             
                                                                            
                      Third Quarter               Third Quarter             
                               2026                        2025             
  MRI                                  606,795                     512,861  
                                       354,953                     290,975  
  PET/CT                                29,750                      22,817  
  Nuclear Medicine                      10,347                       8,965  
  Ultrasound                           771,224                     705,347  
  Mammography                          527,552                     496,465  
  X-ray and Other                      943,648                     889,888  
  Total                              3,244,269                   2,927,318  
                                                                            
* Volumes include wholly owned and joint venture centers.
      
  12  
      
                         RADNET, INC. AND SUBSIDIARIES                          
                                                                                
            SCHEDULE OF ADJUSTED EARNINGS AND EARNINGS PER SHARE (3)            
                                                                                
                        (IN THOUSANDS EXCEPT SHARE DATA)                        
                                                                                
                                  (unaudited)                                   
                                                                                
                   Three Months                                                 
                   Ended                                                        
                   2026            September 30,       2025(iv)  September 30,  
 ────────────────────────────────────────────────────────────────────────────── 
  NET INCOME                                                                    
  (LOSS)                                                                        
  ATTRIBUTABLE                                                                  
  TO               $                       4,153       $                 5,417  
  RADNET,                                                                       
  INC.COMMON                                                                    
  STOCKHOLDERS                                                                  
  Non-cash                                                                      
  impact of                                    –                         2,587  
  cash flow                                                                     
  hedges (i)                                                                    
  Severance                                1,194                         1,441  
  costs                                                                         
  Loss (gain)                                                                   
  on                                                                            
  contribution                                                                  
  of imaging                              (7,528  )                          –  
  centers into                                                                  
  joint                                                                         
  ventures                                                                      
  Non-operatio…                                                                 
  rent expenses                              604                           621  
  (iii)                                                                         
  Loss (gain)                                                                   
  on sale and                                                                   
  disposal of                              5,359                         1,042  
  equipment and                                                                 
  other                                                                         
  Intangibles                                                                   
  Amortization                                                                  
  Expense -                                                                     
  Digital                                  7,260                         3,353  
  Health                                                                        
  Operating                                                                     
  Segment                                                                       
  Non-capitali…                                                                 
  R&D -                                                                         
  DeepHealth                               5,565                         5,486  
  cloud                                                                         
  OS &                                                                          
  generative AI                                                                 
  Legal                                    2,815                             –  
  Settlement                                                                    
  Acquisition                                                                   
  transaction                              2,708                         2,136  
  costs                                                                         
  Non-cash                                                                      
  change to                                8,257                             –  
  contingent                                                                    
  consideration                                                                 
  Lease                                                                         
  abandonment                              2,052                         2,819  
  charges                                                                       
  Total                                                                         
  adjustments -                           28,286                        19.485  
  loss (gain)                                                                   
  Subtract tax                                                                  
  impact of                               (8,596  )                     (6,138  
  Adjustments                                                                   
  (ii)                                                                          
  Tax effected                                                                  
  impact of                               19,690                        13,347  
  adjustments                                                                   
  TOTAL                                                                         
  ADJUSTMENT TO                                                                 
  NET INCOME                                                                    
  ATTRIBUTABLE                            19,690                        13,347  
  TO RADNET,                                                                    
  INC. COMMON                                                                   
  SHAREHOLDERS                                                                  
  ADJUSTED NET                                                                  
  INCOME (LOSS)                                                                 
  ATTRIBUTABLE                            23,843                        18,764  
  TO RADNET,                                                                    
  INC. COMMON                                                                   
  STOCKHOLDERS                                                                  
  WEIGHTED                                                                      
  AVERAGE                                                                       
  SHARES                                                                        
  OUTSTANDING                                                                   
  Diluted                             79,174,226                    77,388,477  
  ADJUSTED                                                                      
  DILUTED NET                                                                   
  INCOME PER                                                                    
  SHARE            $                        0.30       $                  0.24  
  ATTRIBUTABLE                                                                  
  TO RADNET,                                                                    
  INC. COMMON                                                                   
  STOCKHOLDERS                                                                  
                                                                                
                                                                                
         Impact is the sum of (a) the loss in fair value of the hedges          
         during the quarter of $2,371 in 2025 and (b) the amortization of the   
  (i)    accumulation of the changes in fair value out of Other Comprehensive   
         Income that existed prior to the hedges becoming ineffective of $216   
         in 2025.                                                               
  (ii)   Tax effected using 31.5% blended federal and state effective tax       
         rate for 2025 and 30.4% for 2026.                                      
         Represents rent expense associated with de novo sites under            
  (iii)  construction                                                           
         prior to them becoming operational.                                    
         Adjusted from what was reported during last year's third quarter       
         for additional addbacks of (a) $1,042,000 related to Loss (gain) on    
  (iv)   sale and disposal of equipment and other and (b) Intangible            
         amortization                                                           
         expense of the Digital Health operating segment of $3,353,000.         
                                                                                
      
  13  
      
The Company defines Adjusted EBITDA
as earnings before interest, taxes, depreciation and amortization, each from
continuing operations and adjusted for losses or gains on
the sale of equipment, other income or loss, debt extinguishments and non-cash
equity compensation. Adjusted EBITDA includes equity earnings
in unconsolidated operations and subtracts allocations of earnings to non-
controlling interests in subsidiaries, and is adjusted for non-cash
or extraordinary and one-time events taken place during the period.

Adjusted EBITDA is reconciled to its nearest comparable
GAAP financial measure. Adjusted EBITDA is a non-GAAP financial measure used as
analytical indicator by RadNet management and the healthcare
industry to assess business performance, and is a measure of leverage capacity
and ability to service debt. Adjusted EBITDA should not
be considered a measure of financial performance under GAAP, and the items
excluded from Adjusted EBITDA should not be considered in isolation
or as alternatives to net income, cash flows generated by operating, investing
or financing activities or other financial statement data
presented in the consolidated financial statements as an indicator of financial
performance or liquidity. As Adjusted EBITDA is not a
measurement determined in accordance with GAAP and is therefore susceptible to
varying methods of calculation, this metric, as presented,
may not be comparable to other similarly titled measures of other companies.

As noted above, the Company defines
Free Cash Flow as Adjusted EBITDA less total Capital Expenditures (whether
completed with cash or financed) and Cash Interest Expense.
Free Cash Flow is a non-GAAP financial measure. The Company uses Free Cash Flow
because the Company believes it provides useful information
for investors and management because it measures our capacity to generate cash
from our operating activities. Free Cash Flow does not
represent total cash flow since it does not include the cash flows generated by
or used in financing activities. In addition, our definition
of Free Cash Flow may differ from definitions used by other companies.

Free Cash Flow should not be considered a measure
of financial performance under GAAP, and the items excluded from Adjusted EBITDA
should not be considered in isolation or as alternatives
to net income, cash flows generated by operating, investing or financing
activities or other financial statement data presented in the
consolidated financial statements as an indicator of financial performance or
liquidity. As Adjusted EBITDA is not a measurement determined
in accordance with GAAP and is therefore susceptible to varying methods of
calculation, this metric, as presented, may not be comparable
to other similarly titled measures of other companies.

The Company defines Adjusted Earnings
(Loss) Per Share as net income or loss attributable to RadNet, Inc. common
stockholders and excludes losses or gains on the disposal of
equipment, loss on debt extinguishments, bargain purchase gains, severance
costs, loss on impairment, loss or gain on swap valuation,
gain on extinguishment of debt, unusual or non-recurring entries that impact the
Company’s tax provision and any other non-recurring
or unusual transactions recorded during the period.

Adjusted Earnings (Loss) Per Share is reconciled
to its nearest comparable GAAP financial measure. Adjusted Earnings (Loss) Per
Share is a non-GAAP financial measure used as analytical
indicator by RadNet management and the healthcare industry to assess business
performance. Adjusted Earnings Per Share should not be considered
a measure of financial performance under GAAP, and the items excluded from
Adjusted Earnings Per Share should not be considered in isolation
or as alternatives to net income, cash flows generated by operating, investing
or financing activities or other financial statement data
presented in the consolidated financial statements as an indicator of financial
performance or liquidity. As Adjusted Earnings Per Share
is not a measurement determined in accordance with GAAP and is therefore
susceptible to varying methods of calculation, this metric, as
presented, may not be comparable to other similarly titled measures of other
companies.
      
  14  
      

Sources

The 8-K item 2.02 filings (SEC EDGAR) and their EX-99 exhibits: the results release and, when filed, prepared remarks or the call transcript.

Also

Said vs did: the targets in these releases against what was then reported. Filings: every filing.

Work with it

Excel workbook · CSV. Google Sheet that stays up to date: paste =IMPORTDATA("https://tickdelta.com/company/RDNT/export.csv") into a cell.

Next:Presentations
Esc

Type a ticker such as AAPL, a name, an investor such as Buffett, or a topic such as tariffs. ↑ ↓ to move, Enter to open.